
Nicoya Launches Alto Automation Suite to Facilitate SPR Integration Into High-Throughput Biologics Discovery Workflows
January 23, 2025

Nicoya Lifesciences introduces the Alto GxP Suite to help enhance regulatory compliance for drug development
November 12, 2024

Nicoya launches the world’s first SPR instrument subscription plan, empowering early-stage biotech startups
October 15, 2024

Nicoya strengthens presence in China through partnership with TrioBio as Exclusive Distributor
April 16, 2024

Nicoya launches cost-effective and flexible digital SPR solutions to support biologics discovery
March 5, 2024

Nicoya Lifesciences to Further Develop Alto SPR Platform, Enter International Markets
December 21, 2021

Nicoya Extends Series A Financing With Additional $20m to Meet Demand of Rapidly Growing Proteomics Industry
December 16, 2021

Nicoya Lifesciences to receive up to $2 million in response to the Point of Care and Home Diagnostic Kit for COVID-19 challenge
May 26, 2021

Rapid detection of COVID-19 and its variants: Nicoya develops innovative saliva test kit
May 7, 2021

Nicoya Lifesciences receives additional funding for next-phase development of its rapid, saliva-based COVID-19 diagnostic test
Apr 06, 2021

Nicoya receives over $1.9M in funding to continue the development of a portable, saliva-based COVID-19 test
Mar 29, 2021

Nicoya Provides Complimentary Surface Plasmon Resonance Support for Researchers During COVID-19
April 30, 2020

Nicoya Launches Alto, the World’s First Digital Benchtop SPR System, to Accelerate Drug Discovery
January 23, 2020

FedDev Ontario announces a contribution of $2.57 million for Nicoya’s scale-up operations
May 3, 2019

Nicoya Lifesciences raises $2 million to change how the next generation of drugs will be discovered
January 31, 2018